Stocktoria
GeoVax Labs, Inc. GOVX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1994-04-04
GeoVax Labs, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -869.3% | -635.8% | — | -17207.5% | -4862.7% |
| Net margin | -862.3% | -632.0% | — | -17198.3% | -4817.2% |
| FCF margin | -863.8% | -624.5% | — | -23507.2% | -2916.8% |
| Return on assets | -338.5% | -306.4% | -279.7% | -44.7% | -157.4% |
| Return on equity | -561.2% | -495.0% | -450.6% | -52.7% | -425.8% |
| Current ratio | 2.74 | 2.55 | 2.24 | 6.10 | 2.14 |
| Revenue growth | -37.1% | — | -100.0% | -78.9% | -78.9% |
Source: SEC EDGAR filings · CIK 0000832489 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.